Generalized cognitive deficits in schizophrenia: a study of first-episode patients - PubMed (original) (raw)
Generalized cognitive deficits in schizophrenia: a study of first-episode patients
S Mohamed et al. Arch Gen Psychiatry. 1999 Aug.
Abstract
Background: Cognitive impairment is recognized as a core characteristic of schizophrenia. There has always been a debate about the nature, selectivity, and time of onset of these deficits in relationship to the onset of illness and treatment factors. To our knowledge, the present study represents the largest sample of mostly neuroleptic-naive patients with first-episode schizophrenia that has been reported to date.
Methods: A group of 94 patients experiencing their first episode of schizophrenic illness and 305 normal comparison subjects were administered a comprehensive clinical and neuropsychological evaluation. Seventy-three patients were neuroleptic naive, 14 had received treatment for less than 1 week, and the remaining 7 had been medicated for less than 2 weeks.
Results: Patients performed significantly worse than the comparison subjects on every neuropsychological variable except those assessing savings scores (ie, forgetting over time). Twenty-five of 30 tests had an effect size (ES) greater than 0.75 when the 2 groups were compared. An ES analysis within the schizophrenia group revealed that the greatest relative impairments were on the Wechsler Adult Intelligence Scale-Revised digit symbol (ES, -0.52) and comprehension (ES, -0.42) subscales.
Conclusions: Our findings are in concert with others demonstrating that significant cognitive impairment across multiple ability domains is a core characteristic of schizophrenia and is not caused by chronic illness, treatment, or institutionalization. The ES analysis emphasizes that patients with schizophrenia have a generalized deficit that is not easily explained by a single anatomical region or ability area.
Similar articles
- [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Bralet MC, et al. Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French. - Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, Pappadopulos E, Willson DF, Alvir JM, Woerner MG, Geisler S, Kane JM, Lieberman JA. Bilder RM, et al. Am J Psychiatry. 2000 Apr;157(4):549-59. doi: 10.1176/appi.ajp.157.4.549. Am J Psychiatry. 2000. PMID: 10739413 - Distinct contribution of working memory and social comprehension failures in neuropsychological impairment in schizophrenia.
Nestor PG, Niznikiewicz M, McCarley RW. Nestor PG, et al. J Nerv Ment Dis. 2010 Mar;198(3):206-12. doi: 10.1097/NMD.0b013e3181d14143. J Nerv Ment Dis. 2010. PMID: 20215998 - [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
Lecardeur L, Meunier-Cussac S, Dollfus S. Lecardeur L, et al. Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Encephale. 2013. PMID: 23528322 Review. French. - [First-episode psychosis, cognitive difficulties and remediation].
Vidailhet P. Vidailhet P. Encephale. 2013 Sep;39 Suppl 2:S83-92. doi: 10.1016/S0013-7006(13)70101-5. Encephale. 2013. PMID: 24084427 Review. French.
Cited by
- Cognitive remediation in schizophrenia.
Kaneko Y, Keshavan M. Kaneko Y, et al. Clin Psychopharmacol Neurosci. 2012 Dec;10(3):125-35. doi: 10.9758/cpn.2012.10.3.125. Epub 2012 Dec 20. Clin Psychopharmacol Neurosci. 2012. PMID: 23430145 Free PMC article. - Modulation of frontal gamma oscillations improves working memory in schizophrenia.
Singh F, Shu IW, Hsu SH, Link P, Pineda JA, Granholm E. Singh F, et al. Neuroimage Clin. 2020;27:102339. doi: 10.1016/j.nicl.2020.102339. Epub 2020 Jul 10. Neuroimage Clin. 2020. PMID: 32712452 Free PMC article. - Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.
Hasan A, Mitchell A, Schneider A, Halene T, Akbarian S. Hasan A, et al. Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):273-84. doi: 10.1007/s00406-013-0395-2. Epub 2013 Feb 5. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 23381549 Review. - Neuropsychological correlates of diffusion tensor imaging in schizophrenia.
Nestor PG, Kubicki M, Gurrera RJ, Niznikiewicz M, Frumin M, McCarley RW, Shenton ME. Nestor PG, et al. Neuropsychology. 2004 Oct;18(4):629-637. doi: 10.1037/0894-4105.18.4.629. Neuropsychology. 2004. PMID: 15506830 Free PMC article. - Cognitive control deficits in schizophrenia: mechanisms and meaning.
Lesh TA, Niendam TA, Minzenberg MJ, Carter CS. Lesh TA, et al. Neuropsychopharmacology. 2011 Jan;36(1):316-38. doi: 10.1038/npp.2010.156. Epub 2010 Sep 15. Neuropsychopharmacology. 2011. PMID: 20844478 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical